Search results for "drug delivery."

showing 10 items of 692 documents

Mucoadhesive polymers for oral transmucosal drug delivery: a review.

2012

The oral mucosa offers an interesting site for the application of dosage forms that release drugs within/throughout the oral mucosa, by assuring a high drug bioavailability for topic and systemic effects. However, the relative permeability of the oral mucosa and the washing effect related to the oral fluids and mechanical stresses must be considered in the formulation of oral dosage forms. Since a sustained drug release can be guaranteed only if dosage forms remain in contact with the oral site of absorption/application for a prolonged time, the development of mucoadhesive dosage forms is mandatory. The mucoadhesion is a complex phenomenon and the mucoadhesive bond consists of two different…

PolymersBiological AvailabilityPharmacologyDosage formDelayed-Action PreparationsMucoadhesive polymersDrug Delivery SystemsSettore MED/28 - Malattie OdontostomatologicheDrug DiscoverymedicineMucoadhesionAnimalsHumansOral mucosaPharmacologyChemistryMouth MucosaAdhesivenessBioavailabilitymedicine.anatomical_structurePharmaceutical PreparationsMucoadhesion oral transmucosal drug delivery dosage form drug controlled-release mucoadhesive polymers oral mucosa mucosal permeabilitySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDelayed-Action PreparationsDrug deliveryDrug releaseCurrent pharmaceutical design
researchProduct

Uptake of polymeric nanoparticles in a human induced pluripotent stem cell-based blood-brain barrier model: Impact of size, material, and protein cor…

2021

The blood–brain barrier (BBB) maintains the homeostasis of the central nervous system, which is one of the reasons for the treatments of brain disorders being challenging in nature. Nanoparticles (NPs) have been seen as potential drug delivery systems to the brain overcoming the tight barrier of endothelial cells. Using a BBB model system based on human induced pluripotent stem cells (iPSCs), the impact of polymeric nanoparticles has been studied in relation to nanoparticle size, material, and protein corona. PLGA [poly(lactic-co-glycolic acid)] and PLLA [poly(d,l-lactide)] nanoparticles stabilized with Tween® 80 were synthesized (50 and 100 nm). iPSCs were differentiated into human brain m…

PolymersInduced Pluripotent Stem CellsStatic ElectricityGeneral Physics and AstronomyNanoparticleProtein Corona02 engineering and technology010402 general chemistryBlood–brain barrier01 natural sciencesModels BiologicalGeneral Biochemistry Genetics and Molecular BiologyBiomaterialschemistry.chemical_compoundPolylactic Acid-Polyglycolic Acid CopolymermedicineElectric ImpedanceHumansGeneral Materials ScienceParticle SizeInduced pluripotent stem cellEndothelial CellsCell DifferentiationGeneral ChemistryHuman brain021001 nanoscience & nanotechnologyDynamic Light ScatteringFractionation Field Flow0104 chemical sciencesPLGAmedicine.anatomical_structurechemistryBlood-Brain BarrierSelective adsorptionDrug deliveryCalibrationBiophysicsNanoparticlesPolystyrenesProtein Corona0210 nano-technologyBiointerphases
researchProduct

Poly(lactic acid)/carvacrol-based materials: preparation, physicochemical properties, and antimicrobial activity

2020

The current demand for new antimicrobial systems has stimulated research for the development of poly(lactic acid)/carvacrol (PLA/CAR)-based materials able to hinder the growth and spread of microorganisms. The eco-friendly characteristics of PLA and cytocompatibility make it very promising in the perspective of green chemistry applications as material for food and biomedical employments. The broad-spectrum biological and pharmacological properties of CAR, including antimicrobial activity, make it an interesting bioactive molecule that can be easily compounded with PLA by adopting the same techniques as those commonly used for PLA manufacturing. This review critically discusses the most comm…

PolymersPolyestersNanotechnologyAntimicrobial activityApplied Microbiology and Biotechnology03 medical and health scienceschemistry.chemical_compoundstomatognathic systemCarvacrolAntimicrobial activity; Carvacrol; Drug delivery; Food and biomedical application; PLACarvacrolHigh potential030304 developmental biology0303 health sciencesMaterials preparation030306 microbiologyFood PackagingFood and biomedical applicationGeneral MedicineAntimicrobialAnti-Bacterial AgentsLactic acidFood packagingchemistryDrug deliveryDrug deliveryPLACymenesBiotechnologyApplied Microbiology and Biotechnology
researchProduct

Pentafluorophenyl Ester-based Polymersomes as Nanosized Drug-Delivery Vehicles

2015

In this work, activated ester chemistry is employed to synthesize biocompatible and readily functionalizable polymersomes. Via aminolysis of pentafluorophenyl methacrylate-based precursor polymers, an N-(2-hydroxypropyl) methacrylamide (HPMA)-analog hydrophilic block is obtained. The precursor polymers can be versatile functionalized by simple addition of suitable primary amines during aminolysis as demonstrated using a fluorescent dye. Vesicle formation is proven by cryoTEM and light scattering. High encapsulation efficiencies for hydrophilic cargo like siRNA are achieved using dual centrifugation and safe encapsulation is demonstrated by gel electrophoresis. In vitro studies reveal low cy…

PolymersomesMaterials sciencePolymers and Plastics02 engineering and technology010402 general chemistryMethacrylate01 natural scienceschemistry.chemical_compoundAminolysisHPMAPolymer chemistryMaterials ChemistryMethacrylamideReversible addition−fragmentation chain-transfer polymerizationRAFT polymerizationVesicleOrganic Chemistry021001 nanoscience & nanotechnologyCombinatorial chemistry0104 chemical scienceschemistrydrug deliveryPolymersomeDrug deliveryactivated esters0210 nano-technologyDrug carrierMacromolecular Rapid Communications
researchProduct

Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells

2017

The limited efficacy of available treatments for hepatocellular carcinoma (HCC) requires the development of novel therapeutic approaches. We synthesized a novel cationic polymer based on α,β-poly-(N-2-hydroxyethyl)-D,L-aspartamide (PHEA) for drug delivery to HCC cells. The copolymer was synthesized by subsequent derivatization of PHEA with diethylene triamine (DETA) and with a polyethylene glycol (PEG) derivative bearing galactose (GAL) molecules, obtaining the cationic derivative PHEA-DETA-PEG-GAL. PHEA-DETA-PEG-GAL has suitable chemical-physical characteristics for a potential systemic use and can effectively deliver a siRNA (siE2F1) targeted against the transcription factor E2F1, a gen…

Polyplexes HCC siRNA E2F1 PHEA-DETA-PEG-GALCarcinoma HepatocellularPolymersPharmaceutical ScienceE2F1; HCC; PHEA-DETA-PEG-GAL; Polyplexes; siRNA.02 engineering and technologyPolyethylene glycol03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCell Line TumorPEG ratiomedicineHumansE2F1Gene silencingGene SilencingRNA Small InterferingHCCReceptorCell growthChemistryLiver NeoplasmssiRNA.021001 nanoscience & nanotechnologymedicine.diseaseMolecular biologyPHEA-DETA-PEG-GALPolyplexeE2F1030220 oncology & carcinogenesisHepatocellular carcinomasiRNADrug deliveryCancer researchPeptides0210 nano-technologyE2F1 Transcription FactorPolyplexes
researchProduct

Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells

2000

Certain drugs such as dalargin, loperamide or tubocurarine are not transported across the blood-brain barrier (BBB) and therefore exhibit no effects on the central nervous system. However, effects on the central nervous system can be observed when these drugs are loaded onto polybutylcyanoacrylate (PBCA)-nanoparticles and coated with polysorbate 80. The mechanism by which these complexed nanoparticles cross the BBB and exhibit their effects has not been elucidated. Cultured microvessel brain endothelial cells of human and bovine origin were used as an in vitro model for the BBB to gain further insight into the mechanism of uptake of nanoparticles. With cells from these species we were able …

PolysorbateEndotheliumGeneral NeuroscienceConfocalDrug delivery to the brainBiologyBlood–brain barrierchemistry.chemical_compoundmedicine.anatomical_structurechemistryTargeted drug deliveryNanoparticles for drug delivery to the brainImmunologyBiophysicsmedicineMicrovesselEuropean Journal of Neuroscience
researchProduct

Characterization of PLLA scaffolds for biomedical applications

2017

The porosity and pore size distribution of three-dimensional scaffolds have direct implications on their biomedical applications (tissue engineering, drug delivery, and wound dressing). Accordingly, in this paper, a fast, facile, and conservative method relying on low-field nuclear magnetic resonance (LF-NMR) for the evaluation of mean pore size and pore size distribution of polymeric scaffolds is reported. The applicability of the technique is demonstrated on poly-L-lactic acid scaffolds fabricated using the thermal induced phase separation. Results obtained through LF-NMR are successfully compared to scanning electron microscope and X-ray microcomputed tomography micrographs.

Pore sizeScaffoldMaterials sciencePolymers and PlasticsGeneral Chemical EngineeringNanotechnology02 engineering and technologyscaffold010402 general chemistry01 natural sciencesPLLAAnalytical ChemistryTissue engineeringpore size distributionChemical Engineering (all)PorositySettore ING-IND/24 - Principi Di Ingegneria Chimicaintegumentary systemLow-field NMR; phase separation; PLLA; pore size distribution; scaffold; Analytical Chemistry; Chemical Engineering (all); Polymers and Plastics021001 nanoscience & nanotechnology0104 chemical sciencesCharacterization (materials science)Settore ING-IND/22 - Scienza E Tecnologia Dei MaterialiWound dressingDrug deliveryphase separation0210 nano-technologyLow-field NMR
researchProduct

Therapeutic targeting of apoptotic pathways in cancer.

2006

Programmed cell death (apoptosis) is a key tumor suppressor mechanism. Consequently, most if not all cancers develop mechanisms to abolish or circumvent this genetic program. Besides enabling malignant transformation and tumor progression, defects in apoptosis can result in resistance to cytotoxic cancer therapies. Much progress has been made in the delineation of the molecular pathways leading to apoptosis. This allows the identification of target molecules and lead compounds to develop novel therapies, which make use of this intrinsic death program for the treatment of cancer. Here, we review the current understanding of apoptotic signal transduction pathways, and strategies of their ther…

Programmed cell deathClinical BiochemistryAntineoplastic AgentsApoptosislaw.inventionMalignant transformationDrug Delivery SystemslawNeoplasmsDrug DiscoverymedicineAnimalsHumansPharmacologyMechanism (biology)business.industryCancermedicine.diseaseApoptosisTumor progressionGene TargetingCancer researchMolecular MedicineSuppressorSignal transductionbusinessSignal TransductionCurrent drug targets
researchProduct

Involvement of Microglia in Neurodegenerative Diseases: Beneficial Effects of Docosahexahenoic Acid (DHA) Supplied by Food or Combined with Nanoparti…

2021

Neurodegenerative diseases represent a major public health issue and require better therapeutic management. The treatments developed mainly target neuronal activity. However, an inflammatory component must be considered, and microglia may constitute an important therapeutic target. Given the difficulty in developing molecules that can cross the blood–brain barrier, the use of food-derived molecules may be an interesting therapeutic avenue. Docosahexaenoic acid (DHA), an omega-3 polyunsaturated fatty acid (22:6 omega-3), has an inhibitory action on cell death and oxidative stress induced in the microglia. It also acts on the inflammatory activity of microglia. These data obtained in vitro or…

Programmed cell deathDocosahexaenoic AcidsQH301-705.5microgliaApoptosisInflammationReviewPharmacologyProtective AgentsInhibitory postsynaptic potentialmedicine.disease_causeCatalysisInorganic ChemistryDrug Delivery Systemsneurodegenerative diseasemedicineAnimalsHumansBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologySpectroscopychemistry.chemical_classificationMicrogliabusiness.industryOrganic ChemistryNeurodegenerative DiseasesGeneral Medicinedocosahexaenoic acidnanomedicineIn vitroComputer Science ApplicationsDisease Models AnimalOxidative StressChemistryTreatment Outcomemedicine.anatomical_structurechemistryBlood-Brain BarrierinflammationDocosahexaenoic acidDietary SupplementsNanoparticlesmedicine.symptombusinessOxidative stressPolyunsaturated fatty acidInternational Journal of Molecular Sciences
researchProduct

Targeting Mitochondria: A New Promising Approach for the Treatment of Liver Diseases

2010

Mitochondrial dysfunction acts as a common pathogenetic mechanism in several acute and chronic liver diseases, such as Alcoholic and Non-Alcoholic Fatty Liver Disease (NAFLD), drug-induced steatohepatitis, viral hepatitis, biliary cirrhosis, hepatocellular carcinoma, ischemia/reperfusion injury and transplant rejection. In particular mitochondrial uncoupling has been recently identified to play a determinant role in the pathogenesis of liver diseases by causing decrease of mitochondrial proton motive force and ATP depletion. Damaged mitochondria present defects in lipid homeostasis, bioenergetics impairment and overproduction of Reactive Oxygen Species (ROS), leading to lipid accumulation a…

Programmed cell deathMitochondrionBiologymedicine.disease_causeBiochemistryLiver diseaseDrug Delivery SystemsDrug DiscoverymedicineAnimalsHumansPharmacologychemistry.chemical_classificationReactive oxygen speciesCell DeathLiver DiseasesOrganic ChemistryFatty livermedicine.diseaseMitochondriaOxidative StressBiochemistrychemistryCancer researchMolecular MedicineSteatohepatitisReactive Oxygen SpeciesReperfusion injuryOxidative stressCurrent Medicinal Chemistry
researchProduct